Do Patients Desire Liposomal Bupivacaine After Wisdom Teeth Surgery
An interesting article titled “Are Patients Interested in Liposomal Bupivacaine as a Nonopioid Alternative for Postsurgical Analgesia Following Third Molar Extractions?” written by Annie Ho and et. al. appears in the Journal of Oral and Maxillofacial Surgery (online August 9, 2023). The article seeks to determine a patient interest in the use of Liposomal Bupivacaine as an alternative to opioids after wisdom teeth extraction. Studies have shown that patients given opioids after surgery have a 44% increased risk of long-term opioid use. Long lasting local anesthetics like liposomal bupivacaine (LB) were first approved in the U.S by the Food and Drug Administration in2011. Only a single dose to the surgical site is needed for postsurgical analgesia. Research has shown that Liposomal Bupivacaine can lower cumulative pain scores, reduce opioid requirements, and make for faster discharges from the hospital. Although Liposomal … Read more